4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-047745
President and CEO sold 27,796 shares at an average $35.75 ($993,652)
- President and CEO acquired 27,796 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2021-07-20 | Option exercise | +1,029 | $0.53 | $545 | 13,499 | D: show line 1 in the form |
| Mack David Henry President and CEO | 2021-07-20 | Sale | −1,029 | $35.53 | $36,560 | 12,470 | D: show line 2 in the form |
| Mack David Henry President and CEO | 2021-07-21 | Option exercise | +26,767 | $0.53 | $14,187 | 39,237 | D: show line 3 in the form |
| Mack David Henry President and CEO | 2021-07-21 | Sale | −26,767 | $35.76 | $957,092 | 12,470 | D: show line 4 in the form |
| Open-market sales · 27,796 sh · avg $35.75 · $993,652 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2021-07-20 | Option exercise · Stock Option (right to buy) | −1,029 | 473,841 | D: show line 5 in the form | ||
| Mack David Henry President and CEO | 2021-07-21 | Option exercise · Stock Option (right to buy) | −26,767 | 447,074 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…